142 related articles for article (PubMed ID: 9866902)
1. A simple screening test for the detection of heterozygous beta thalassemia.
Thool AA; Walde MS; Shrikhande AV; Talib VH
Indian J Pathol Microbiol; 1998 Oct; 41(4):423-6. PubMed ID: 9866902
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of naked eye single tube red cell osmotic fragility test in detecting beta-thalassemia trait.
Raghavan K; Lokeshwar MR; Birewar N; Nigam V; Manglani MV; Raju NB
Indian Pediatr; 1991 May; 28(5):469-72. PubMed ID: 1752672
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta-thalassaemia trait.
Singh SP; Gupta SC
Singapore Med J; 2008 Oct; 49(10):823-6. PubMed ID: 18946618
[TBL] [Abstract][Full Text] [Related]
4. 'NESTROFT'--an effective screening test for beta thalassemia trait.
Manglani M; Lokeshwar MR; Vani VG; Bhatia N; Mhaskar V
Indian Pediatr; 1997 Aug; 34(8):702-7. PubMed ID: 9492398
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of simple erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and Beta-thalassemia trait in pregnant women.
Tongprasert F; Sirichotiyakul S; Piyamongkol W; Tongsong T
Gynecol Obstet Invest; 2010; 69(4):217-220. PubMed ID: 20068326
[TBL] [Abstract][Full Text] [Related]
6. Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
Mamtani M; Jawahirani A; Das K; Rughwani V; Kulkarni H
Hematology; 2006 Aug; 11(4):277-86. PubMed ID: 17178668
[TBL] [Abstract][Full Text] [Related]
7. Screening for beta-thalassaemia carriers in Egypt: significance of the osmotic fragility test.
El-Beshlawy A; Kaddah N; Moustafa A; Mouktar G; Youssry I
East Mediterr Health J; 2007; 13(4):780-6. PubMed ID: 17955759
[TBL] [Abstract][Full Text] [Related]
8. [Osmotic resistance of erythrocytes as a screening method in detecting heterozygotes in beta-thalassemia].
Nastev B; Efremov GD; Petkov G
Bilt Hematol Transfuz; 1977; 5(3-4):89-94. PubMed ID: 615615
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and molecular basis of beta-thalassemia in Isparta province and region.
Tunç B; Cetin H; Gümrük F; Istanbullu B; Yavrucuoğlu H; Kurt U; Genç H
Turk J Pediatr; 2002; 44(1):18-20. PubMed ID: 11858373
[TBL] [Abstract][Full Text] [Related]
10. Is NESTROFT sufficient for mass screening for beta-thalassaemia trait?
Mamtani M; Das K; Jawahirani A; Rughwani V; Kulkarni H
J Med Screen; 2007; 14(4):169-73. PubMed ID: 18078560
[TBL] [Abstract][Full Text] [Related]
11. NESTROFF as a screening test for detection of Beta-thalassemia trait.
Bobhate SK; Gaikwad ST; Bhaledrao T
Indian J Pathol Microbiol; 2002 Jul; 45(3):265-7. PubMed ID: 12785163
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of single-tube osmotic fragility as a screening test for thalassemia.
Chow J; Phelan L; Bain BJ
Am J Hematol; 2005 Jul; 79(3):198-201. PubMed ID: 15981230
[TBL] [Abstract][Full Text] [Related]
13. NESTROFT as a screening test for the detection of thalassaemia & common haemoglobinopathies--an evaluation against a high performance liquid chromatographic method.
Thomas S; Srivastava A; Jeyaseelan L; Dennison D; Chandy M
Indian J Med Res; 1996 Aug; 104():194-7. PubMed ID: 8840659
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of a new osmotic test in the screening of heterozygous beta thalassemias.
Anichini P; Reynaudo G; Pacini G
Scand J Clin Lab Invest; 1983 Apr; 43(2):171-3. PubMed ID: 6612224
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye.
Mohapatra R; Warang P; Ghosh K; Colah R
Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
[TBL] [Abstract][Full Text] [Related]
17. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
[TBL] [Abstract][Full Text] [Related]
18. Validity of Nestroft in screening and diagnosis of beta-thalassemia trait.
Gomber S; Sanjeev ; Madan N
J Trop Pediatr; 1997 Dec; 43(6):363-6. PubMed ID: 9476460
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits.
Sirichotiyakul S; Maneerat J; Sa-nguansermsri T; Dhananjayanonda P; Tongsong T
J Obstet Gynaecol Res; 2005 Jun; 31(3):198-201. PubMed ID: 15916654
[TBL] [Abstract][Full Text] [Related]
20. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia.
Fucharoen G; Sanchaisuriya K; Sae-ung N; Dangwibul S; Fucharoen S
Bull World Health Organ; 2004 May; 82(5):364-72. PubMed ID: 15298227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
